229 related articles for article (PubMed ID: 15541717)
1. MHC class II biosynthesis by activated rat CD4+ T cells: development of repression in vitro and modulation by APC-derived signals.
Mannie MD; Dawkins JG; Walker MR; Clayson BA; Patel DM
Cell Immunol; 2004 Jul; 230(1):33-43. PubMed ID: 15541717
[TBL] [Abstract][Full Text] [Related]
2. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
3. MHC class-II-restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders.
Mannie MD; Norris MS
Cell Immunol; 2001 Aug; 212(1):51-62. PubMed ID: 11716529
[TBL] [Abstract][Full Text] [Related]
4. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes.
Patel DM; Dudek RW; Mannie MD
Cell Immunol; 2001 Nov; 214(1):21-34. PubMed ID: 11902826
[TBL] [Abstract][Full Text] [Related]
5. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation.
Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK
Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753
[TBL] [Abstract][Full Text] [Related]
6. Expression of major histocompatibility complex class II but not of CD8 molecules by lectin-stimulated peripheral CD4+ T cells in LEC mutant rats.
Sakai T; Agui T; Matsumoto K
Cell Immunol; 1994 Oct; 158(2):414-22. PubMed ID: 7923392
[TBL] [Abstract][Full Text] [Related]
7. MHC class II-independent and -dependent T cell expansion and B cell hyperactivity in vivo in mice deficient in CD152 (CTLA-4).
Stohl W; Xu D; Kim KS; David CS; Allison JP
Int Immunol; 2004 Jul; 16(7):895-904. PubMed ID: 15136557
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
Dembic Z; Schenck K; Bogen B
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
[TBL] [Abstract][Full Text] [Related]
9. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
10. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells.
Kitamura H; Kamon H; Sawa S; Park SJ; Katunuma N; Ishihara K; Murakami M; Hirano T
Immunity; 2005 Nov; 23(5):491-502. PubMed ID: 16286017
[TBL] [Abstract][Full Text] [Related]
11. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
[TBL] [Abstract][Full Text] [Related]
12. Intercellular exchange of class II major histocompatibility complex/peptide complexes is a conserved process that requires activation of T cells but is constitutive in other types of antigen presenting cell.
Patel DM; Mannie MD
Cell Immunol; 2001 Dec; 214(2):165-72. PubMed ID: 12088415
[TBL] [Abstract][Full Text] [Related]
13. Activation of MHC-restricted rat T cells by cloned syngeneic thyrocytes.
Hirose W; Lahat N; Platzer M; Schmitt S; Davies TF
J Immunol; 1988 Aug; 141(4):1098-102. PubMed ID: 2899600
[TBL] [Abstract][Full Text] [Related]
14. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
[TBL] [Abstract][Full Text] [Related]
15. Regulation of memory CD4 T cell adhesion by CD4-MHC class II interaction.
Metz DP; Farber DL; Konig R; Bottomly K
J Immunol; 1997 Sep; 159(6):2567-73. PubMed ID: 9300674
[TBL] [Abstract][Full Text] [Related]
16. BALB/c invariant chain mutant mice display relatively efficient maturation of CD4+ T cells in the periphery and secondary proliferative responses elicited upon peptide challenge.
Kenty G; Bikoff EK
J Immunol; 1999 Jul; 163(1):232-41. PubMed ID: 10384121
[TBL] [Abstract][Full Text] [Related]
17. Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells.
Arnold PY; Davidian DK; Mannie MD
Eur J Immunol; 1997 Dec; 27(12):3198-205. PubMed ID: 9464806
[TBL] [Abstract][Full Text] [Related]
18. A role for the Hsp90 molecular chaperone family in antigen presentation to T lymphocytes via major histocompatibility complex class II molecules.
Rajagopal D; Bal V; Mayor S; George A; Rath S
Eur J Immunol; 2006 Apr; 36(4):828-41. PubMed ID: 16552710
[TBL] [Abstract][Full Text] [Related]
19. Invariant chain+ N2a neuroblastoma cells stably expressing the class II MHC transactivator CIITA fail to stimulate anti-tumor immunity.
Rickard S; Ono SJ
Exp Mol Pathol; 2008 Dec; 85(3):147-54. PubMed ID: 18952077
[TBL] [Abstract][Full Text] [Related]
20. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
